Camille L Bedrosian Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

Camille L Bedrosian is Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 155,243 shares of AMLX, which is worth approximately $294,961. The most recent transaction as insider was on Apr 16, 2024, when has been sold 96,910 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K

166.13% 3M change

n/a 12M change

Total Value Held $294,961

Camille L Bedrosian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 16 2024	BUY Grant, award, or other acquisition	-	96,910 Added 38.43%	155,243 Common Stock
Nov 27 2023	BUY Grant, award, or other acquisition	-	58,333 Added 50.0%	58,333 Common Stock

Also insider at

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

EVP and Chief Medical Officer

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

CLB